Showing results (1271-1280 of 1,380) with videos related to
Sort By:
Pageof 138
Neuron|November 9, 2007
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuliWilliam Renthal, Ian Maze, Vaishnav Krishnan, et al.European Journal of Pharmacology|August 31, 2020
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseasesMaryanne Covington, Xin He, Monika Scuron, et al.The Journal of Pharmacology and Experimental Therapeutics|April 15, 2006
Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammationAnuk M Das, Krishna G Vaddi, Kimberly A Solomon, et al.Cancer|August 24, 2017
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinomaMaeve A Lowery, Kenneth H Yu, David Paul Kelsen, et al.Clinical Chemistry and Laboratory Medicine|March 8, 2006
Recommendation for measuring and reporting chloride by ISEs in undiluted serum, plasma or bloodMohammed C Ben Rayana, Robert W Burnett, Arthur K Covington, et al.Clinical Chemistry and Laboratory Medicine|May 19, 2005
Guidelines for sampling, measuring and reporting ionized magnesium in undiluted serum, plasma or blood: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): IFCC Scientific Division, Committee on Point of Care TestingMohammed C Ben Rayana, Robert W Burnett, Arthur K Covington, et al.Neuromodulation : Journal of the International Neuromodulation Society|March 6, 2026
A Multicenter Analysis of Baseline Patient-Reported Outcome Measures as Predictors of Progression From Spinal Cord Stimulator Trial to ImplantationSebastian Encalada, Matthew A Cascio, Eva Kubrova, et al.Journal of Medicinal Chemistry|April 17, 2026
Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual InhibitorBo Wei, Xiaolei Li, Jacob J Lacharity, et al.Future Oncology (London, England)|November 25, 2021
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile testSherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, et al.Frontiers in Oncology|January 11, 2021
A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted ActivityJonathan Rios-Doria, Margaret Favata, Kerri Lasky, et al.Pageof 138